CalciMedica, Inc.
CALC· Nasdaq
Filed Aug 11, 2023 · 10-Q · 42 days after period end · 0000950170-23-041844
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$6.30M | -$3.03M | -$7.71M | -$5.87M |
| EPS Diluted | -$1.11 | -$36.55 | -$0.36 | -$6.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CalciMedica, Inc. · CIK 1534133 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 11, 2023 · 42 d after period end